TG Therapeutics | Ordinære Aksjekapital

Ordinary Share Capital Endring Dato
Ardelyx USD 23K 1000 2023-09
Arrowhead Research USD 200K 0 2023-12
Bayer EUR 2.52B 0 2023-09
Dynavax Technologies USD 130K 1000 2023-12
Gilead Sciences USD 1000K 0 2023-09
Roche Holding CHF 107M 0 2023-06
Vertex Pharmaceuticals USD 2.6M 0 2023-09



TG Therapeutics Ordinære Aksjekapital - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2024.